Affimed Announces Successful Completion of First Dose Cohort in First-in-Human Phase 1/2A Study of AFM24 for the Treatment of Advanced EGFR-Expressing Solid Tumors Including Colon, Lung and Other Cancers
June 17, 2020
June 17, 2020
June 16, 2020
June 11, 2020
May 29, 2020
May 28, 2020
May 15, 2020
April 28, 2020
April 16, 2020
April 2, 2020
April 2, 2020